^○後藤 悌¹, 仁保 誠治², 駄賀 晴子³, 榊原 純⁴, 田中 洋史⁵, 大橋 圭明⁶, 豊澤 亮⁷, 小谷 昌広⁸, 高橋 利明⁹, 服部 剛弘¹⁰, 森瀬 昌宏¹¹, 池田 喬哉², 松本 慎吾², 葉 清隆², 野村 尚吾¹², 後藤 功一² (1.国立がん研究センター中央病院, 2.国立がん研究センター東病院, 3.大阪市立総合医療センター, 4.北海道大学病院, 5.新潟県立がんセンター新潟病院, 6.岡山大学病院, 7.国立病院機構九州がんセンター, 8.鳥取大学, 9.静岡県立がんセンター, 10.兵庫県立がんセンター, 11.名古屋大学医学部, 12.東京大学)

^○豊澤 亮¹, Suresh S. Ramalingam², Ferdinandos Skoulidis³, Ramaswamy Govindan⁴, Vamsidhar Velcheti⁵, Bob T. Li⁶, Benjamin Besse⁷, Grace K. Dy⁸, Dong-Wan Kim⁹, Martin Schuler¹⁰, Mark Vincent¹¹, Frederick Wilson¹², Joseph Park¹³, Juan E. Gutierrez¹⁴, Qui Tran¹³, Simon P. Jones¹³, Juergen Wolf¹⁵ (1.Division of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 2.Winship Cancer Institute, Emory University School of Medicine, 3.University of Texas M.D. Anderson Cancer Center, 4.Alvin J. Siteman Cancer Center, Washington University School of Medicine, 5.Perlmutter Cancer Center, NYU Langone, 6.Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, 7.Gustave Roussy Institute, 8.Roswell Park Cancer Institute, 9.Seoul National University Hospital, 10.West German Cancer Center, University Hospital Essen, 11.London Regional Cancer Program, 12.Yale School of Medicine, 13.Amgen Inc, 14.Cedimed-Quiron Salud, 15.University Hospital Cologne)

^○後藤 悌¹, T. Li Bob², F. Smit Egbert³, 中川 和彦⁴, 宇田川 響⁵, Mazières Julien⁶, Nagasaka Misako⁷, Bazhenova Lyudmila⁸, Saltos Andreas N.⁹, Felip Enriqueta¹⁰, Pacheco Jose M.¹¹, Pérol Maurice¹², Paz-Ares Luis¹³, Saxena Kapil¹⁴, 志賀 遼太¹⁴, Cheng Yingkai¹⁴, Acharyya Suddhasatta¹⁴, Shahidi Javad¹⁴, Planchard David¹⁵, A. Jänne Pasi¹⁶ (1.国立がん研究センター中央病院, 2.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 3.Netherlands Cancer Institute, Amsterdam, Netherlands, 4.近畿大学病院, 5.国立がん研究センター東病院, 6.Institut Universitaire du Cancer, Toulouse, France, 7.Karmanos Cancer Institute, Detroit, MI, USA, 8.University of California San Diego Moores Cancer Center, San Diego, CA, USA, 9.Moffitt Cancer Center, Tampa, FL, USA, 10.Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain, 11.University of Colorado, Aurora, CO, USA, 12.Centre Léon Bérard, Lyon, France, 13.Hospital Universitario 12 de Octubre, Madrid, Spain, 14.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 15.Gustave Roussy, Villejuif, France, 16.Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA)

^○Masahiro Morise¹, Hiroshi Sakai², Terufumi Kato³, Shingo Matsumoto⁴, Toru Kumagai⁵, Tomohiro Sakamoto⁶, Takaaki Tokito⁷, Shinji Atagi⁸, Toshiyuki Kozuki⁹, Hiroaki Takeoka¹⁰, Kenichi Chikamori¹¹, Naofumi Shinagawa¹², Hiroshi Tanaka¹³, Tomonori Hirashima¹⁴, S Peter Eggleton¹⁵, Rolf Bruns¹⁶, Gordon Otto¹⁷, Paul Paik^18,19 (1.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2.Department of Thoracic Oncology, Saitama Cancer Center, Kitaadachi-gun, Japan, 3.Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, 4.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa City, Japan, 5.Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka City, Japan, 6.Department of Respiratory Medicine, Tottori University Hospital, Yonago City, Japan, 7.Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Japan, 8.Department of Thoracic Oncology, NHO Kinki-Chuo Chest Medical Center, Sakai City, Japan, 9.Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama City, Japan, 10.Department of Respiratory Medicine, NHO Kyushu Medical Center, Fukuoka City, Japan, 11.Department of Oncology, NHO Yamaguchi - Ube Medical Center, Ube City, Japan, 12.Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 13.Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan, 14.Department of Pulmonary Oncology, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Japan, 15.Global Clinical Development, Merck Serono Limited, Feltham, UK, a subsidiary of Merck KGaA, Darmstadt, Germany, 16.Department of Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany, 17.Global Clinical Development, Merck Healthcare KGaA, Darmstadt, Germany, 18.Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, 19.Department of Medicine, Weill Cornell Medical College, New York, NY, USA)

^○豊澤 亮¹, 野崎 要², 下川 元継³, 堀之内 秀仁⁴, 森瀬 昌宏⁵, 大橋 圭明⁶, 村上 晴泰⁷, 里内 美弥子⁸, 榊原 純⁹, 矢野 聖二¹⁰, 松本 慎吾², 後藤 功一², 瀬戸 貴司¹, 葉 清隆² (1.九州がんセンター 呼吸器腫瘍科, 2.国立がん研究センター東病院 呼吸器内科, 3.山口大学大学院医学系研究科 医学統計学分野, 4.国立がん研究センター中央病院 呼吸器内科, 5.名古屋大学医学部附属病院 呼吸器内科, 6.岡山大学病院 呼吸器・アレルギー内科, 7.静岡がんセンター 呼吸器内科, 8.兵庫県立がんセンター 呼吸器内科, 9.北海道大学病院 内科I, 10.金沢大学 がん進展制御研究所／腫瘍内科)

^○Toshio Shimizu¹, Satoru Kitazono², Edward B Garon³, Melissa L Johnson⁴, Aaron Lisberg³, Alexander Spira⁵, Noboru Yamamoto¹, Rebecca S Heist⁶, Jacob M Sands⁷, Funda Meric-Bernstam⁸, Yoshitaka Zenke⁹, Noriko Yanagitani², Jonathan Greenberg¹⁰, Fumiaki Kobayashi¹¹, Yui Kawasaki¹¹, Kiyotaka Yoh⁹ (1.National Cancer Center Hospital, Tokyo, Japan, 2.The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, 3.David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, 4.Sarah Cannon Research Institute, Tennessee Oncology, PLLC, One Oncology, Nashville, TN, USA, 5.Virginia Cancer Specialists and US Oncology Research, Fairfax, VA, USA, 6.Massachusetts General Hospital, Boston, MA, USA, 7.Dana-Farber Cancer Institute, Boston, MA, USA, 8.The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 9.National Cancer Center Hospital East, Chiba, Japan, 10.Daiichi Sankyo, Inc, Basking Ridge, NJ, USA, 11.Daiichi Sankyo Co, Ltd, Tokyo, Japan)